Apellis to Present New Data Reinforcing EMPAVELI™ (pegcetacoplan) Efficacy and Safety in Patients with PNH at the 2021 ASH Annual Meeting
November 04, 2021 09:17 ET
|
Apellis Pharmaceuticals, Inc.
Results from positive Phase 3 PRINCE study in treatment-naïve patients with PNH accepted for oral presentation In new analysis, EMPAVELI demonstrated clinically meaningful improvements in key markers...
Imara to Present Clinical and Preclinical Data at the American Society of Hematology (ASH) Annual Meeting 2021
November 04, 2021 09:17 ET
|
Imara, Inc.
Tovinontrine (IMR-687) VOC data in patients with sickle cell disease from ongoing Phase 2a open-label extension study and preclinical models of beta-thalassemia to be presented Oral presentation...
Liquid Media’s iNDIEFLIX Elevates Christine Laskin to Chief Operating Officer
November 04, 2021 09:15 ET
|
Liquid Media Group Ltd.
VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Liquid Media Group Ltd. (the “Company,” “Liquid Media” or “Liquid”) (Nasdaq: YVR) today announced that iNDIEFLIX, a member of the...
Athenex Presents Interim Data from ANCHOR Study of KUR-502 (Allogeneic CD19 CAR-NKT Cells) in Relapsed or Refractory Lymphoma and Leukemia at 63rd ASH Annual Meeting and Exposition
November 04, 2021 09:15 ET
|
Athenex, Inc.
Results from five patients showed best responses of 2 partial responses (PR), 1 complete response with incomplete hematological recovery (CRi) and 1 complete response (CR). Updated data show...
North Bay Resources Inc. (NBRI) Reports on Tulameen Platinum Project Assays
November 04, 2021 09:15 ET
|
North Bay Resources Inc.
Skippack, PA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- North Bay Resources Inc. (OTC: NBRI) (“North Bay” or the “Company”) is pleased to announce that lab results from recent fieldwork at the Company’s...
Vor to Present New Platform and Preclinical Data at ASH
November 04, 2021 09:15 ET
|
Vor Biopharma
Knock out of CD123 or CLL-1 by CRISPR-Cas9 from Human Hematopoietic Stem Cells Maintains Hematopoietic Function and is Resistant to Targeted TherapiesMultiplex Engineering of Human CD34+ HSPCs Enables...
Tejon Ranch Co. Announces Third Quarter 2021 Financial Results
November 04, 2021 09:15 ET
|
Tejon Ranch Co
TEJON RANCH, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results...
NextCure Announces Presentations on Targets in Development by Collaborators at American Society of Hematology Annual Meeting
November 04, 2021 09:15 ET
|
NextCure
BELTSVILLE, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
Splash Beverage Group’s TapouT Performance Drink Gets Rebrand: Enhanced Ergonomic Bottle & Clean Ingredients
November 04, 2021 09:15 ET
|
SPLASH BEVERAGE GROUP INC.
Fort Lauderdale, Florida, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company"), a portfolio company of leading beverage brands, today...
Viemed Healthcare to Present at the Stifel 2021 Virtual Healthcare Conference
November 04, 2021 09:15 ET
|
Viemed Healthcare, Inc.
LAFAYETTE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation’s largest...
- September 25, 2024 20:42 ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
- September 25, 2024 20:29 ET SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GitLab